BILL Holdings Valuation
Is 0A75 undervalued compared to its fair value, analyst forecasts and its price relative to the market?
Valuation Score
4/6Valuation Score 4/6
Unter dem Marktwert
Deutlich unter dem Marktwert
Price-To-Sales gegen Gleichaltrige
Price-To-Sales gegen Industrie
PM vs. Fair Ratio
Analysten-Prognose
Share Price vs Fair Value
What is the Fair Price of 0A75 when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.
Unter dem Marktwert: 0A75 ($69.09) wird unter unserer Schätzung des Fair Value ($70.33) gehandelt.
Deutlich unter dem Marktwert: 0A75 unter dem beizulegenden Zeitwert gehandelt wird, jedoch nicht um einen signifikanten Betrag.
Key Valuation Metric
Which metric is best to use when looking at relative valuation for 0A75?
Other financial metrics that can be useful for relative valuation.
What is 0A75's n/a Ratio? | |
---|---|
n/a | 0x |
n/a | n/a |
Market Cap | US$6.62b |
Key Statistics | |
---|---|
Enterprise Value/Revenue | 5x |
Enterprise Value/EBITDA | -59.3x |
PEG Ratio | n/a |
Price to Sales Ratio vs Peers
How does 0A75's PS Ratio compare to its peers?
Company | Forward PS | Estimated Growth | Market Cap |
---|---|---|---|
Peer Average | 6.2x | ||
SGE Sage Group | 5.7x | 8.6% | UK£12.5b |
IQG IQGeo Group | 5.7x | 12.1% | UK£254.8m |
GBG GB Group | 2.4x | 5.8% | UK£664.7m |
CER Cerillion | 11.1x | 11.1% | UK£433.8m |
0A75 BILL Holdings | 5.6x | 13.2% | US$6.6b |
Price-To-Sales gegen Gleichaltrige: 0A75 ist ein guter Wert, wenn man sein Price-To-Sales Verhältnis (5.4x) mit dem Durchschnitt der anderen Unternehmen (6.5x) vergleicht.
Price to Earnings Ratio vs Industry
How does 0A75's PE Ratio compare vs other companies in the GB Software Industry?
Price-To-Sales gegen Industrie: 0A75 ist teuer, wenn man sein Price-To-Sales Verhältnis (5.4x) mit dem UK Software Branchendurchschnitt (2.7x) vergleicht.
Price to Sales Ratio vs Fair Ratio
What is 0A75's PS Ratio compared to its Fair PS Ratio? This is the expected PS Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.
Fair Ratio | |
---|---|
Current PS Ratio | 5.6x |
Fair PS Ratio | 11.3x |
PM vs. Fair Ratio: 0A75 ist ein guter Wert auf der Grundlage des Verhältnisses Price-To-Sales (5.4x) im Vergleich zum geschätzten fairen Verhältnis Price-To-Sales (11.8x).
Analyst Price Targets
What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?
Date | Share Price | Average 1Y Price Target | Dispersion | High | Low | 1Y Actual price | Analysts |
---|---|---|---|---|---|---|---|
Current | US$62.01 | US$87.09 +40.4% | 14.5% | US$110.00 | US$60.00 | n/a | 23 |
Mar ’25 | US$65.58 | US$87.43 +33.3% | 13.7% | US$110.00 | US$65.00 | n/a | 23 |
Feb ’25 | US$78.36 | US$85.88 +9.6% | 15.5% | US$110.00 | US$61.00 | n/a | 24 |
Jan ’25 | US$82.74 | US$83.17 +0.5% | 17.3% | US$110.00 | US$61.00 | n/a | 23 |
Dec ’24 | US$67.29 | US$85.57 +27.2% | 20.9% | US$130.70 | US$61.00 | n/a | 24 |
Nov ’24 | US$87.28 | US$130.99 +50.1% | 19.0% | US$200.00 | US$90.00 | n/a | 25 |
Oct ’24 | US$109.05 | US$132.33 +21.4% | 19.5% | US$200.00 | US$90.00 | n/a | 23 |
Sep ’24 | US$117.22 | US$131.30 +12.0% | 20.4% | US$200.00 | US$73.00 | n/a | 24 |
Aug ’24 | US$124.58 | US$131.76 +5.8% | 20.9% | US$200.00 | US$69.00 | n/a | 24 |
Jul ’24 | US$117.84 | US$119.01 +1.0% | 22.8% | US$200.00 | US$69.00 | n/a | 24 |
Jun ’24 | US$104.93 | US$117.69 +12.2% | 22.8% | US$200.00 | US$69.00 | n/a | 25 |
May ’24 | US$77.31 | US$117.03 +51.4% | 25.6% | US$200.00 | US$55.00 | n/a | 25 |
Apr ’24 | US$80.83 | US$127.47 +57.7% | 24.6% | US$200.00 | US$55.00 | US$69.09 | 25 |
Mar ’24 | US$83.82 | US$135.94 +62.2% | 18.3% | US$200.00 | US$95.00 | US$65.58 | 23 |
Feb ’24 | US$113.68 | US$163.77 +44.1% | 22.8% | US$250.00 | US$105.00 | US$78.36 | 24 |
Jan ’24 | US$109.41 | US$182.20 +66.5% | 16.5% | US$250.00 | US$110.00 | US$82.74 | 22 |
Dec ’23 | US$125.46 | US$182.20 +45.2% | 16.5% | US$250.00 | US$110.00 | US$67.29 | 22 |
Nov ’23 | US$131.92 | US$201.20 +52.5% | 18.4% | US$300.00 | US$110.00 | US$87.28 | 22 |
Oct ’23 | US$136.02 | US$214.24 +57.5% | 15.7% | US$300.00 | US$143.00 | US$109.05 | 21 |
Sep ’23 | US$149.13 | US$215.21 +44.3% | 16.2% | US$300.00 | US$143.00 | US$117.22 | 19 |
Aug ’23 | US$134.91 | US$184.32 +36.6% | 25.2% | US$300.00 | US$125.00 | US$124.58 | 19 |
Jul ’23 | US$112.76 | US$199.28 +76.7% | 23.2% | US$300.00 | US$125.00 | US$117.84 | 18 |
Jun ’23 | US$113.60 | US$202.22 +78.0% | 22.0% | US$300.00 | US$125.00 | US$104.93 | 18 |
May ’23 | US$177.03 | US$305.47 +72.6% | 15.7% | US$380.00 | US$200.00 | US$77.31 | 17 |
Apr ’23 | US$226.00 | US$309.94 +37.1% | 16.0% | US$380.00 | US$200.00 | US$80.83 | 16 |
Analysten-Prognose: Das Kursziel liegt mehr als 20% über dem aktuellen Aktienkurs, und die Analysten liegen in einem statistisch sicheren Bereich der Übereinstimmung.